Adidas released its third Balenciaga collaboration last week, marking a €450 average retail price point across the collection. The German sportswear maker has now shipped collections with Balenciaga, Gucci, and Wales Bonner in the past 14 months, none of which feature athlete names on the hangtag. Nike spent the same period renewing 37 athlete contracts across basketball, football, and track. Anta bought 8.7% more global sponsorship inventory in that window, mostly in tier-two football leagues and regional basketball.

The divergence is structural, not cyclical. Adidas is treating athlete endorsements as a cost center and luxury partnerships as margin expansion. Nike is defending existing athlete relationships at higher rates to protect retail shelf space. Anta is buying scale to justify its $52 billion market cap, which now sits $11 billion above Adidas. All three face the same problem: a 22% decline in full-price sneaker sell-through since early 2023, which makes every marketing dollar harder to justify.

Adidas's luxury pivot carries two risks. The Wales Bonner collaboration moved 94% of inventory in the first 48 hours, but at 3,200 total units that is a rounding error against the 240 million pairs Adidas ships annually. The margin is real—Balenciaga collabs carry 68% gross margin versus 44% on standard performance footwear—but the volume ceiling is obvious. More immediately, Adidas is ceding athlete mindshare to Nike and Anta at the exact moment when NIL deals have made college athletes worth owning early. Nike signed 140 collegiate athletes in the past 16 months. Adidas signed 11.

Anta's strategy is blunt-force acquisition. The company bought Amer Sports for $5.2 billion in 2019, gaining Wilson, Salomon, and Arc'teryx. It now owns 19 brands and operates 13,400 retail doors across 28 countries. Anta's athlete roster includes Kyrie Irving, whose signature shoe moved 2.1 million pairs in its first 11 months, and Klay Thompson, whose recent move to Dallas extended Anta's NBA visibility. The company is undercutting Nike on renewal rates by 15-20% in markets where Nike holds legacy deals, particularly Southeast Asia and Eastern Europe. Anta's advantage is capital structure: it can afford to lose money on athlete deals if it drives retail traffic to higher-margin Arc'teryx and Salomon inventory.

Nike remains the largest athlete spender by a factor of 3x, but the company is now defending rather than expanding. Jordan Brand renewed 12 of its 18 top basketball athletes in the past 10 months, paying an average 19% premium over expiring contracts. That protects shelf space at Foot Locker and Finish Line, where Nike still commands 38% of basketball SKU allocation, but it compresses operating margin. Nike's total athlete spend rose $340 million year-over-year while revenue from signature footwear fell 7%, a gap that suggests the endorsement ROI model is weakening. The company is not abandoning athletes—it cannot afford to—but it is now paying more for less incremental revenue.

Sponsor CMOs should watch Adidas's Q2 2025 margins, reported in early August, to see if luxury collabs move the operating income needle or remain a storytelling exercise. Anta's FY24 results, due in March, will clarify whether scale is translating to profitability outside China. Nike's next 10-K filing will show total athlete spend as a percentage of revenue for the first time since 2019, a disclosure the company added under pressure from activist investors.

The fashion collaborations are working, but only for Adidas's brand perception among 27-to-44-year-old consumers who do not buy performance product. Anta's scale is real, but its margin profile still lags Nike by 1,100 basis points. Nike is paying more to stand still. One of these strategies stops working in the next 18 months.